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Abstract— Aging and diabetes lead to protein glycation
and cause dysfunction of collagen-containing tissues. The
accompanying structural and functional changes of col-
lagen significantly contribute to the development of vari-
ous pathological malformations affecting the skin, blood
vessels, and nerves, causing a number of complications,
increasing disability risks and threat to life. In fact, no
methods of non-invasive assessment of glycation and as-
sociated metabolic processes in biotissues or prediction of
possible skin complications, e.g., ulcers, currently exist for
endocrinologists and clinical diagnosis. In this publication,
utilizing emerging photonics-based technology, innovative
solutions in machine learning, and definitive physiological
characteristics, we introduce a diagnostic approach capa-
ble of evaluating the skin complications of diabetes mellitus
at the very earlier stage. The results of the feasibility stud-
ies, as well as the actual tests on patients with diabetes and
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healthy volunteers, clearly show the ability of the approach
to differentiate diabetic and control groups. Furthermore,
the developed in-house polarization-based hyperspectral
imaging technique accomplished with the implementation
of the artificial neural network provides new horizons in the
study and diagnosis of age-related diseases.
Index Terms— Hyperspectral imaging, polarization, dia-
betes mellitus, skin complications.
I. INTRODUCTION
ACCORDING to the International Diabetes Federation, theproblem of early diagnosis and monitoring the effective-
ness of diabetes mellitus (DM) treatment is one of the most
acute in modern healthcare. In 2019, there were 463M patients
with DM in the world, and by 2045 this figure is to increase
to 700M [1]. DM is one of the ten deadliest diseases with
a yearly mortality rate of over 1M. Recent studies [1] have
demonstrated that timely diagnosis and treatment, including
enhancement of the patient control, reduce complications and
make it possible to reverse their development if detected at
the early preclinical stages.
In people with DM, over time, high blood glucose level
(known as hyperglycemia) causes damage to many biological
tissues in the body that leads to the development of disability-
causing and life-threatening medical complications. One of
the consequences of DM is the appearance of foot tissue
lesions (diabetic foot syndrome). The main factor in the
pathogenesis of foot tissue lesions at DM is a violation of
blood microcirculation. Recent studies [2] have revealed that
microvascular lesions in various organs, including the feet,
are registered already in the first years of diabetes and even at
prediabetic conditions long before the clinical manifestations
of vascular complications. Therefore, increasing the effective-
ness of prevention and treatment of diabetic angiopathies is
possible only with timely diagnosis and correction of vascular
disorders at early stages. Timely detection of microvascular
disorders followed by the appropriate treatment reduces the
risk of complications and makes it possible to reverse their
development at the early preclinical stage [3]. The incidence
of microangiopathies depends not only on the duration of DM
but also on how early the correct diagnosis has been performed
as well as on the effectiveness of the treatment. To date, a
common disadvantage of the methods available to clinicians
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for the diagnosis of complications of DM is the inability to
noninvasively assess the degree of tissue glycation and monitor
its metabolism, as well as to determine the location of skin
areas most probably exposed to the development of trophic
ulcers. One of the ways to improve the quality of diagnosis
in modern medicine and advanced medical/biological research
is to use the methods of optical diagnostics, many of which
are successfully applied in clinical practice, e.g. microscopy
techniques [4], pulse oximetry and photoplethysmography
(PPG) [5], optical coherence tomography (OCT) [6], indocya-
nine green fluorescent imaging [7], etc. The advantages of such
techniques are associated with their non-invasiveness, high
resolving power, low procedure cost, and high productivity.
Using a priori data along with the information obtained by
non-invasive optical imaging methods, as well as advanced
approaches to data mining would allow identifying the pa-
tients with an increased risk of diabetic foot syndrome and
assessing the areas of the lower extremities most prone to the
development of ulcerative defects.
Diffuse reflectance spectroscopy (DRS) has found its appli-
cation in many areas of medicine [8], including endoscopic
diagnosis of cancer [9], [10], cancer surgery [11], derma-
tology [12], etc. Analysis of the changes in the spectrum
of diffuse reflectance of tissues can provide rich information
about their physiological and morphological state. DRS tech-
nique has been implemented to assess the peripheral blood
flow and the oxygen saturation. The method is able to provide
continuous non-invasive measurement of oxy- (HbO2) and de-
oxyhaemoglobin (Hb) concentrations. By recording a diffuse
reflectance spectrum, it is possible to determine the oxygen
saturation of the tissue, using the spectrum shape (its slope,
area under the curve) on the basis of mathematical simulations
of the relation between the reflectance and concentration of the
Hb/HbO2 [13].
Hyperspectral imaging (HSI) is a modern implementation
of the DRS method providing information about the tissue
functional state. To implement hyperspectral measurements, a
series of images of the object under study are registered in
narrow wavelength ranges. Analysis of the hyperspectral data
allows one to assess the content of the main absorbers in the
biological tissue, blood volume, oxygen saturation, etc.
This method is widely used in various medical appli-
cations [14], [15]. It is also able to detect systemic and
local microcirculatory changes associated with DM [13]. The
technology is most commonly used to analyze the develop-
ment of wounds, including diabetic ulcers, burns [16] and
bruises [17]. Studies conducted in DM using HSI technology
have shown the ability of the method not only to evaluate
the effectiveness of the therapy of diabetic ulcers, but also
to predict their development even before they appear [18]–
[20]. It was concluded that HSI can accurately predict ulcer
healing during a few months and identify ulcers that are at
risk of not healing and therefore, could be used to screen
for lower extremity complications due to DM [13]. Thus,
the development of portable and low-cost imaging systems
demonstrates a strong potential for the implementation of
hyperspectral imaging technology in our everyday life and the
day-to-day practice of clinicians.
However, the considered HSI techniques utilize DRS
primarily for the assessment of specific tissue chro-
mophores/absorbers concentration. In this case, the possible
changes in the scattering properties caused by the alteration
in the sample structure are not directly taken into account.
At the same time, changes in the structural properties
of the skin are an important factor in assessing skin aging
and diabetic complications. Endogenous processes in diabetes
that trigger skin aging include excessive free radical produc-
tion, nuclear/mitochondrial gene mutation, cellular senescence,
shortening of telomere, reduced cell proliferation, and im-
paired immune functioning [21], [22]. In recent years, many
scientific studies have revealed that advanced glycation end
products (AGEs) are also among the crucial contributing
factors of skin aging [21], [23], [24]. Skin aging is also
associated with microstructural changes in collagen and its
molecular organization [25]. Atomic force microscopy study
of skin biopsy samples [26] has shown the changes in the
mechanical properties of collagen in diabetes. In particular,
the changes include a violation of the integrity of dermal
collagen, disorganization of collagen fibrils, and nanoscale
fragmentation (see the schematic illustration of the age-related
and diabetic changes in human skin in the Fig. 1).
Fig. 1. Schematic illustration of the age-related and diabetic changes
in human skin. Broken collagen and elastin fibers and reduced fibroblast
size are the hallmarks of structural changes in aging and diabetic skin.
It is known that collagen is one of the main skin constituents
defining its optical scattering as well as birefringent proper-
ties [27]. The magnitude of scattering and birefringence is
related to the density and other mechanical properties of the
collagen fibers [28]–[30]. Recent cohort studies have shown
that skin aging and related collagen changes have a high
inverse correlation with skin scattering properties [31], [32].
A young and healthy skin with an unfragmented collagen
structure has an increased scattering coefficient in comparison
to the aged skin, which leads to a decrease in the degree of the
polarization of the scattered polarized light [33]. Therefore, the
polarization of light will also be sensitive to age and structural
changes in the skin. It has already been shown that the degree
of residual polarization (DOP) is a sensitive parameter to
the changes in the structure of collagen fibers [29], [34]–
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[36]. In particular, polarization methods were used to assess
microstructural changes in biological tissues caused by can-
cer [37], [38], diabetes wounds [39], burns [40], [41], neurode-
generation [42], [43], etc. Thus, polarization-sensitive methods
also look promising for assessing the skin condition in case
of age-related and diabetic changes. Supplementary Figure 1
shows the general principle of diagnostics of structural changes
in the skin, based on the registration of the parameter of the
DOP.
Here we introduce a novel polarization-enhanced neural
network-assisted hyperspectral method for monitoring blood
content, blood oxygenation, and structural changes in the skin
of patients with DM. To the best of our knowledge, the current
work is the first one that applies hyperspectrally-resolved
polarization index for in vivo study of diabetic patients and
Monte Carlo-trained artificial neural networks for processing
the hyperspectral data. Here, we perform the proof-of-concept
studies for our approach and report the first clinical application
of the system. Our system is ready for wide clinical use as a
universal tool for label-free non-contact identification of DM
complications.
II. METHODS
A. Hyperspectral imaging system
A compact imaging system [44] (see Fig. 2a,b and Supple-
mentary Figure 2) was built on the basis of the hyperspectral
snapshot camera (Senop Optronics, Finland) utilizing a micro
Fabry-Perot tunable filter providing spectral resolution of 6–
10 nm within the wavelength range of 510–900 nm (see
Supplementary Table 1).
A halogen broadband illumination unit is based on a fiber-
optic ring illuminator (Edmund Optics, USA) providing a
uniform distribution of light intensity in the camera focal
plane. This ring illuminator allows to combine the lighting
and detection axes. Normalized spatially-resolved reflectance
was defined as a ratio of dark-noise-corrected light intensity
reflected from the skin and that reflected from the Gray Spec-
tralon diffuse reflectance standard (50% reflection, Labsphere,
Inc., USA). A data from the reflectance standard was recorded
every time before the measurement of an object. In general,
the developed device is capable of recording spatially and
spectrally resolved light reflectance used for further artificial
neural network (ANN) analysis. For a detailed description,
see the Neural networks section. The developed HSI system
is primarily sensitive to the variations of blood content in
the papillary dermis, upper blood net plexus, and is able to
cover the top part of the reticular dermis (see Supplementary
Methods, Supplementary Figure 3 and Supplementary Movie
1). It is worth noting the system and data processing approach
has been verified by measurements on phantoms and different
ethnic skin types in Ref. 44.
In the present study, we also adapt this system to measure
the degree of linear polarization (DOLP) of radiation reflected
from a biological tissue. In general, total DOP can be derived
from the components of the corresponding Stokes vector.
However, in some cases, the determination of all elements
of the Stokes vector is redundant [29] and using other polar-
ization states would significantly complicate the system and
its ability to be used in in vivo clinical conditions [45]–[47].
The system was equipped with a rotating linear polarizer,
which can be placed either parallel or perpendicular to the
initial polarization of the light source. Accounting for the
DOLP of the light scattered from a sample significantly
improves the imaging contrast between slightly different tissue
structures and offers in consequence a sensitive parameter for
the discriminant analysis [48]. In addition, the normalization
of the difference image by the sum image cancels the variation
in the illumination and the melanin effect [29]. As a diagnostic
criterion, the polarization index (PI) is proposed in this study.
PI represents the integrated value of DOLP spectrum nor-
malized by the number of bands of the hyperspectral camera
(see bellow). When measuring blood volume fraction (BVF)
and skin blood oxygenation (SBO), the rotating polarizer was
fixed in the crossed position in respect to the polarizer on the
illumination ring for the reduction of specular reflection from
the measured object.
B. Data pre-processing






where Itissue is the measured diffuse reflectance in the biolog-
ical tissue, Ispectralon is the measured diffuse reflectance of the
grey spectralon diffuse reflectance standard, and Idark is the
dark counts measured from the sensor.






where I‖ and I⊥ are, respectively, the backscattered intensities
for parallel and perpendicular orientation of the polarizers.







where λmin = 510 nm and λmax = 900 nm define the borders
of the considered spectral range, and B = 79 is the number of
spectral bands of the setup. The normalization to the spectral
bands number allows one to get the average value of DOLP
that is ranged from 0 to 1.
C. Neural networks
Matlab R2018b Deep Learning Toolbox was adapted to
build and train a set of ANN for the retrieval of skin pa-
rameters. For the training of ANN and estimation of BVF and
SBO, the diffuse reflectance spectra of the skin for all possible
combinations of the considered parameters were simulated by
GPU-accelerated Monte Carlo technique [49], [50].
A main flowchart of data processing is demonstrated in
Fig. 2c. The data processing steps can be divided into two
groups. The first group consisting of the training dataset
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Fig. 2. Presented compact, hand-held hyperspectral imaging system can be easily applied for imaging in an arbitrary selected area of skin. (a)
The setup has been verified in measurements of the palmar skin surface. (b) In clinical studies of DM patients, the system has been purposed
for measurements in the dorsal surface of feet. (c) Flowchart of data processing. Blocks 1–3 are performed prior to the measurements. Block 4 is
performed in line with the data acquisition.
modeling and training the ANN is performed prior to the
measurements. The second group is the use of the trained
ANN for processing the hyperspectral measurements results
and reconstruction of the target parameters. The normalization
procedure was implemented in the data processing algorithm
and dedicated to the mitigation of possible height variations
of the skin surface in the camera field of view. The vector
normalization (by L2-norm) for both the training dataset and
the measured data was used to obtain the corresponding unit
vectors. The detailed description of the hyperspectral system
and algorithms for data processing are presented in Ref. 44 and
Supplementary Methods. The developed approach is capable
of close to real-time hyperspectral image processing. It should
be noted that our approach provides measurement values close
to the absolute values of blood volume in the tissue, the
accuracy of which is determined by the developed numerical
model of the skin.
D. Ethics
The healthy volunteer group was assembled through an
internal university advertising campaign. According to the
University of Oulu Ethics Committee regulations, informed
consent was obtained from all volunteers. The clinical study
protocol was approved by the local ethics committee from
03.04.2019 (protocol No. 28). All studies were conducted
in accordance with the principles set out in the Helsinki
Declaration of 2013 by the World Medical Association.
E. Statistics
Nonparametric Mann-Whitney U-test was used to confirm
the reliability of differences in the results. Values of p < 0.01
were considered significant. The relationship of parameters
was estimated using Pearson’s correlation coefficient. A linear
discriminant analysis was used to determine the discriminant
function. To ensure the stability of the classifier and avoid
over-fitting was used lave-one-out cross-validation. The quality
of discriminant analysis was evaluated using the ROC-curve.
III. RESULTS
A. System validation
The developed HSI system was used to perform trial mea-
surements including the arterial and venous occlusion tests
in healthy volunteers. Caucasian male skin corresponding to
the type II of Fitzpatrick scale was considered. The skin
surface position relative to the axis of linear polarizer of the
illumination unit was fixed for the measurement of all patients
and healthy volunteers. During the measurements, the axis
was directed along the measured limb. At the same time,
our studies have shown that the object position practically
does not affect the measurement of BVF and SBO. This is
achieved by orthogonal illumination and a stable distance
to the object, which is controlled by the length of the lens
hood. Arterial occlusion and venous occlusion tests were
performed on the upper arm using a sphygmomanometer air
cuff with a pressure of 200–220 mmHg and 80–100 mmHg,
correspondingly. Additionally, finger occlusion test has been
performed. During the finger occlusion, to suppress blood
circulation and oxygenation the ring finger of the right hand
was occluded with a elastic band. Hyperspectral images of
the skin of the palm and fingers before the occlusion, after
3 min of continuous occlusion, and 1 min after the release
of the occluded arm and ring finger were obtained. Each
occlusion test was a separate measurement with a significant
time interval in between to enable full tissue recovery.
In the experimental study, BVF and SBO were assessed by
the developed neural network-assisted HSI method. Hyper-
spectral images of the inner side of the fingers and the palm
were obtained (see Fig. 2a and Supplementary Figure 6). 2D
distribution maps of BVF and SBO were reconstructed. The
melanin content and epidermal thickness of skin have been
taken into account to obtain correct values of blood fraction
and oxygenation for different skin types. The epidermis thick-
ness was fixed at the typical average thickness [51] of 100
µm. The average value of melanin content is 1%, which is
typical for Caucasian skin.
Fig. 3a–d present the reconstructed maps of BVF of the palm
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Fig. 3. Retrieved maps of BVF and SBO before, during, and 1 min after different occlusion tests indicate the high repeatability of the measuring
procedure. (a) Palm with upper arm arterial occlusion. (b) Fingers with upper arm arterial occlusion. (c) Fingers with upper arm venous occlusion.
(d) Fingers with arterial occlusion of one finger. (e-h) Corresponding maps of SBO before, during, and 1 min after different occlusion tests for the
considered skin zones. (i) Mean values and standard deviation of BVF for each stage of occlusion. (j) Mean values and standard deviation of SBO
for each stage of occlusion.
and fingers during the different occlusion tests performed.
During the arterial occlusion of the palm and fingers (Fig. 3a,b)
and finger occlusion by elastic band (Fig. 3d) the significant
decrease in blood content is observed. Venous occlusion
(Fig. 3c) greatly increases the blood content in the fingers,
which is associated with the cessation of blood outflow. When
the pressure in the cuff is low, only the veins are squeezed,
while maintaining the arterial blood flow. The release of the
occlusion cuff or occlusion ring causes the reactive hyperemia,
which leads to an increase in BVF parameter.
Fig. 3e–h show the distribution maps of the SBO parameter
before, during, and after the different occlusion tests for the
considered skin zones. The average SBO level is of 80–85% for
not occluded tissues. These values correspond to the average
oxygen saturation between the arterial (95–99%) and venous
(˜75%) blood [52]. The 3-minute finger occlusion reduces the
blood oxygen content to the level of 60–65% (Fig. 3h). More
gentle arterial and venous occlusions lower the oxygenation
values to 70–75% (Fig. 3e–g). It can be seen that the decrease
in oxygenation in venous occlusion is more local. After the
release of the occlusion, the oxygenation quickly restored to
its initial value. The mean values and standard deviation of
BVF and SBO for each stage of different occlusion tests are
presented in Fig. 3i,j, correspondingly.
Preliminary studies of the capacity of the proposed PI
parameter for monitoring the age-related human skin changes
were also conducted. For this purpose, 32 healthy volunteers
(9 males and 23 females, aged 22–76 yr) were recruited. Hy-
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Fig. 4. Polarization sensitive hyperspectral system allows one to identify the age-specific changes. (a-c) Retrieved PI maps for healthy female
volunteers: (a) 23 yr; (b) 52 yr; (c) 71 yr. Region of interest (blue rectangle, 8×8 mm) indicates the averaging area to obtain the DOLP spectra.
(d) DOLP spectra for two age groups: 22–40 and 47–76 yr. (e) Comparison of PI among two age groups. (f) Correlation between PI and age (gray
circle – 22–40 yr; orange circle – 47–76 yr, confidence level is 95%).
perspectral images of the skin at the parallel and perpendicular
orientation of the polarizers were recorded on the palm dorsal
surface. Fig. 4a-c show examples of the PI images for three
female volunteers of different ages. A general increase of the
PI parameter is observed with an age. For the detailed analysis,
the volunteers were divided into two age groups: 22–40 and
47–76 yr.
Fig. 4d shows the spectral distributions of the DOLP of ra-
diation backscattered from skin at different ages. The spectral
dependences of the DOLP are affected by the presence of skin
absorbers (e.g., blood, melanin) and scatterers (e.g., collagen,
elastin). A statistically significant increase of PI parameter for
elderly group (47–76 yr) is observed (Fig. 4e). In particular,
the average value of PI for this group is 76% higher than
for younger volunteers (22–40 yr). Fig. 4f shows the relation-
ship between the PI and the age (r=0.89, p<0.001, Pearson
correlation). The increase can be explained by the negative
correlation between the skin scattering coefficient and the
human age demonstrated in Ref. 31. Specifically, a decrease
in the concentration of skin collagen during aging [28] causes
the decrease in the skin scattering. However, for the polarized
light, the multiple scattering results in a loss of polarization.
Thus, the low values of the scattering coefficient in older age
lead to lower depolarization and, as a consequence, to higher
values of DOLP. The proposed approach shows promise for
in vivo non-invasive real-time assessment of age-related skin
changes and can be also extended to monitor the changes
associated with the development of DM.
B. Clinical study of diabetic patients
The experimental clinical study involved 20 patients (10
men and 10 women, mean age 54 ± 11 yr) with Caucasian
skin type and with type 2 DM at the Medical Center Plavnieki
and the Pauls Stradins Clinical University Hospital (Riga,
Latvia). The control group consisted of 20 healthy volunteers
(mean age 48 ± 14 yr). 13 participants (65%) were women.
The main characteristics of the target groups are presented in
Table I. The compared groups are statistically homogeneous
with a difference in fasting glucose level and body mass index
(p<0.01, Mann-Whitney U-test).
The measurements were performed on the dorsal surface of
the foot (see Fig. 2b and Supplementary Figure 6). All studies
were performed in the sitting position. The study participants
refrained from food and drink two hours before the study to
exclude the influence of these factors on the microcirculation.
Room temperature was maintained steadily at 24–25 ◦C.
Hyperspectral images of the dorsal surface of the foot of
patients with DM were obtained. Moreover, 2D distribution
maps of BVF and SBO were reconstructed, the melanin content
and the epidermal thickness of skin have been taken into
account. Fig. 5a,b show the measurement area (field of view
(FOV) of HSI system) with the calculated parameters of
BVF and SBO, respectively. Typical distribution maps of the
calculated parameters for the control and the diabetic groups
are presented in Fig. 5c–h.
All parameters were averaged over the FOV of the system.
Experimental studies have shown that diabetic patients have
elevated values of BVF and PI, as well as a lower SBO level
(see Fig. 6a).
The results of the computation of BVF show that high blood
content is observed in DM patients. This can be explained
by a number of factors. When venous stasis, associated with
venous insufficiency characteristic of diabetic patients [53],
all functioning veins become wider, and those venous vessels
that had not previously functioned are open. Capillaries also
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TABLE I
CHARACTERISTICS OF DIABETIC PATIENTS AND CONTROL GROUP.
Characteristics Diabetic group Control group p value
Gender, M/F 10/10 7/13 0.35, NS
Age, yr 54± 11 48± 14 0.17, NS
Systolic BP, mmHg 139± 19 131± 9 0.16, NS
Diastolic BP, mmHg 81± 7 79± 5 0.35, NS
Body mass index, kg/m2 34.6± 5.8 23.2± 2.2 < 0.001
Fasting glucose, mmol/l 8.7± 3.1 4.7± 0.5 < 0.001
Diabetes duration, y 15± 10 – –
HbA1c, % 8.3± 1.6 – –
HbA1c, mmol/mol 67± 9 – –
Total cholesterol, mmol/l 5.3± 1.2 – –
Creatinine, µmol/l 79± 26 – –
ALT, IU/L 31± 8 – –
Microvascular disease, % – – –
Polyneuropathy 95 – –
Angiopathy 20 – –
Retinophaty 45 – –
Nephropathy 75 – –
Stage of diabetes, % – – –
Compensated 30 – –
Subcompensated 70 – –
Note: The data are mean ± SD unless stated otherwise. NS=not significant.
Note: Reference values of the laboratory: HbA1c 4.0% to 6.0%, total cholesterol 3.5 to 5.0
mmol/l, creatinine 70 to 110 µmol/l, and ALT 10 to 38 IU/L.
Fig. 5. The developed hyperspectral system is capable of reliably visualising the BVF and SBO parameters in the dorsal surface of feet. (a,b) FOV
of the HSI system (8×8 cm2) with the calculated parameters of (a) BVF and (b) SBO. (c-h) Typical reconstructed maps of the BVF (c, f), SBO (d,
g) and PI (e, h) for the control (upper row, c-e) and diabetic (lower row, f-h) groups, correspondingly.
expand, mainly in the venous parts. The elevated values of
this parameter can also be accounted for by a blood flow to
the lower limbs due to inflammation and healing processes,
which can be observed in patients with DM [1]. For patients
with DM, it is also necessary to take into account the presence
of complex cardiovascular pathology and nephropathy, which
can lead to variations in blood content.
The obtained data on understated tissue saturation in di-
abetics in comparison with the control group match those
previously obtained by other studies [54]–[56]. It is known
that hyperglycemia may increase oxygen consumption in mi-
tochondria, resulting in cellular hypoxia [57], [58]. In this
regard, the retrieval of blood content and oxygen saturation
can be useful in the study of blood stasis, leading to edema
and trophic disorders, as well as in monitoring therapeutic
procedures aimed at healing trophic ulcers.
Fig. 6b shows the averaged spectra of DOLP for control and
diabetes groups with the difference in the entire wavelength
range. It should be noted that the spectral dependences of the
DOLP reflect the presence of blood in the skin tissue (an
increase in the DOLP in the spectral bands of hemoglobin
absorption) [59]. In this regard, to assess the influence of blood
content on the difference in the spectra, the dependence of PI
from BVF was plotted. As can be seen from Fig. 6c there is no
statistically significant correlation between these parameters.
We assume that it is the presence of diabetes and associated
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Fig. 6. The parameters of BVF, SBO, and PI were found to have statistically significant difference between the control and the diabetic groups. (a)
Comparison of parameters between control (CG, blue bars) and diabetic (DG, red bars) groups. The box central line is the median of the group, the
edges are the 25th and 75th percentiles. (b) Mean spectral dependences of the DOLP (solid line) and standard deviation for two groups: control
(blue line) and diabetes (red line). (c,d) Correlation between (c) PI and BVF and between (d) PI and age for diabetes group (confidence level is
95%).
skin changes that affect the difference in DOLP spectra.
Considering the connection of diabetic changes and aging
processes [1], [21], we assume that the presence of DM as
well as aging reduces the loss of polarization. Additionally,
we checked the relationship between PI and age for the
diabetic group. As can be seen from the Fig. 6d, there is also
no correlation between these parameters. This confirms the
assumption that the presence of diabetes is the main factor
affecting the polarization properties of patients’ skin.
The analysed parameters (BVF, SBO, and PI) were used
for the synthesis of the decision rule. These parameters satisfy
the principles of statistical independence and the significance
of the differences of their values, calculated for the patients’
and control groups (see Fig. 6a). Table II summarises the
sensitivity, specificity, and area under the curve (AUC) for
a different combination of measured parameters. As can be
seen from the table, the combination of all three parameters
provides the highest sensitivity and specificity values.
TABLE II
SENSITIVITY, SPECIFICITY, AND AUC FOR THE CLASSIFICATION RULE.
Parameter BVF, SBO BVF, PI SBO, PI BVF, SBO, PI
Sensitivity 0.85 0.80 0.95 0.95
Specificity 0.80 0.80 0.80 0.85
AUC 0.94 0.93 0.96 0.97
Fig. 7a shows the 3D scatter plot of experimental data with
the applied discriminant surface that divides the experimental
points into two groups with better combination of sensitivity
and specificity. The phenomenological diagnostic criterion in
the form of discriminant functions (D) allows for attributing
a newly measured subject to one of the two groups:
D = 8.9 + 0.5BV F − 0.2SBO + 28.9PI . (4)
The ROC-curves and integral characteristic of AUC were
calculated for the obtained discriminant functions (see Fig. 7b
and Table II).
IV. DISCUSSION
The developed hyperspectral system has shown the ability to
sense the alterations of blood content, blood oxygenation, and
collagen structure in human skin in vivo. The implementation
of the ANN-based processing allows for fast recovery of the
considered skin parameters. Our concept was successfully
demonstrated in preclinical experiments and clinical studies
and satisfied the major requirements for modern medical
imaging techniques by providing: high FOV, high spectral
resolution, close to real-time data acquisition and processing,
high level of sensitivity and specificity.
This is the first in vivo human clinical study to report
a label-free, non-invasive polarization-sensitive approach that
can discriminate between the skin of DM patients and control
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Fig. 7. The simultaneously measured values of BVF, SBO, PI underlies the set of developed diagnostic classifiers of high sensitivity and specificity.
(a) The 3D scatter plot and the decision surface for a three-dimensional LDA classifier. 3D ellipsoids are confidence regions (confidence level is
95%). (b) ROC curves for assessing the effectiveness of the classifiers. The healthy group is shown by blue circles, the diabetic group by red circles.
For the ROC analysis: blue line denotes BVF, SBO, black line – BVF, PI, red line – SBO, PI, green line – BVF, SBO, PI.
participants. We showed that polarization-enhanced hyperspec-
tral analysis can differentiate the skin tissue with age-related
and DM changes. We assume that the shown differences in the
PI parameter, characterizing the age-related collagen changes,
can form the basis for the diagnosis of DM complications.
Prediction of ulcers can also be based on the detection of
changes in collagen structure. Fig. 6d shows the absence of
correlation between the age of the patients with diabetes and
PI. In the same time, a significant correlation is observed for
the control group of healthy volunteers. It can be explained by
the fact that the presence of diabetes can distort the collagen
structure at any age and thus hinders the dependence of PI
on the age for diabetic group. That, in particular, supports our
suggestion of the sensitivity of PI to the changes in collagen
structure that is altered in the presence of diabetes (Fig. 6a). It
should be borne in mind that the blood content in the biotissue,
epidermis thickness, and some other factors may specifically
affect the residual polarization spectra. Thus, hyperspectral
polarization imaging, in contrast to the standard approach with
the registration of reflected light, allows for more detailed
tissue analysis, including selectively tracking changes in the
concentration of various absorbers and scatterers in the biotis-
sue.
Nonetheless, for future clinical applications, our technique
can be improved and expanded. The developed data pro-
cessing algorithm allows almost real-time processing of the
hyperspectral images, however, the time of the hypercube
acquisition and the duration of the data transfer via USB
port impose the main limitation on the system performance.
The hyperspectral sensor with specific spectral resolution and
wavelength range could be flexibly optimised according to
application requirements. In this study, a spectral band of 510–
900 nm was utilized. However, the application of a sensor with
an extended spectral range up to 1000 nm may provide an
additional possibility to analyze the content of water and fat
in tissues. Additionally, the use of UV or blue sources in the
lighting channel will allow the HSI method to be used for the
fluorescence analysis of AGEs, as well as the respiratory chain
coenzymes NADH and FAD [60], [61]. There is also further
potential to expand the number of clinical investigations that
will eventually allow the methods in question to be introduced
into the practice of the attending physician.
In summary, we have developed a compact HSI system
utilizing ANN-based processing approach for the calculation
of distribution maps of skin blood content, blood oxygenation,
and the polarization index of the reflected radiation. The pro-
posed system is capable of close to real-time hyperspectral im-
age processing. The use of polarization-sensitive hyperspectral
imaging and parameters of BVF, SBO, and PI in combination
or individually can have important clinical applications since
they can help to identify patients with different degrees of
microcirculation impairments in the lower extremities. The
proposed parameters could serve as biomarkers of diabetic
complications. They can also be used to evaluate therapeutic
procedures aimed at preventing or reversing diabetic com-
plications. Employment of the PI parameter increases the
sensitivity and specificity of the method up to the level of 95%
and 85%, respectively, compared to the approach that relies
only on BVF and SBO (sensitivity 85%, specificity 80%). Our
results can facilitate the development of the HIS technique and
give a new direction in the studies of age-related diseases.
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